Tumor microenvironment and the role of mesenchymal stromal cells

Neoplasma

Volumn 60, Issue 1, 2013, Pages 1-10

  Kucerova, L ^a   Skolekova, S ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Human mesenchymal stromal cells; Malignant cells; Paracrine interaction; Tumor microenvironment

Indexed keywords

CYTOKINE; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADIPOCYTE; ANGIOGENESIS; CANCER INHIBITION; CELL CULTURE; CELL INVASION; CELL PROLIFERATION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATORY CELL; MESENCHYMAL STROMA CELL; METASTASIS; MIGRATION; NEOPLASM; PHENOTYPE; REVIEW; SOLID TUMOR; STROMA; SURVIVAL; TUMOR MICROENVIRONMENT; XENOGRAFT; ANIMAL; PATHOLOGY;

ANIMALS; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84879023571     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_001     Document Type: Review

References (88)

1. EGEBLAD M, NAKASONE E, WERB Z Tumors as organs: complex tissues that interface with the entire organism. Dev Cell 2010; 18: 884-901. http://dx.doi.org/10.1016/j.devcel.2010.05.012
2. HU M, POLYAK K Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 2008; 44: 2760-2765. http://dx.doi.org/10.1016/j.ejca.2008.09.038
3. KORKAYA H, LIU S, WICHA MS Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 2011; 121: 3804-3809. http://dx.doi.org/10.1172/JCI57099
4. FIDLER IJ, POSTE G The "seed and soil" hypothesis revisited. Lancet Oncol 2008; 9: 808. http://dx.doi.org/10.1016/S1470-2045(08)70201-8
5. PAGET S The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8: 98-101.
6. LIN HJ, ZUO T, CHAO JR, PENG Z, ASAMOTO LK et al. Seed in soil, with an epigenetic view. Biochim Biophys Acta 2009; 1790: 920-924.
7. RIBATTI D, VACCA A The role of microenvironment in tumor angiogenesis. Genes Nutr 2008; 3: 29-34. http://dx.doi.org/10.1007/s12263-008-0076-3
8. OSTMAN A, AUGSTEN M Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev 2009; 19: 67-73. http://dx.doi.org/10.1016/j.gde.2009.01.003
9. SHIMODA M, MELLODY KT, ORIMO A Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010; 21: 19-25. http://dx.doi.org/10.1016/j.semcdb.2009.10.002
10. XOURI G, CHRISTIAN S Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 2010; 21: 40-46. http://dx.doi.org/10.1016/j.semcdb.2009.11.017
11. ORIMO A, GUPTA PB, SGROI DC, ARENZANA-SEISDEDOS F, DELAUNAY T et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121: 335-348. http://dx.doi.org/10.1016/j.cell.2005.02.034
12. MISHRA J, HUMENIUK R, MEDINA DJ, ALEXE G, MESIROV JP et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68: 4331-4339. http://dx.doi.org/10.1158/0008-5472.CAN-08-0943
13. SPAETH EL, DEMBINSKI AK, SASSER K, WATSON A, KLOPP B et al. Mesenchymal stem cell transition to tumorassociated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009; 4: e4992. http://dx.doi.org/10.1371/journal.pone.0004992
14. ROORDA BD, TER ELST A, KAMPS WA, DE BONT ES Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol 2009; 69: 187-198. http://dx.doi.org/10.1016/j.critrevonc.2008.06.004
15. DIRAT B, BOCHET L, DABEK M, DAVIAUD D, DAUVILLIER S et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011; 71: 2455-2465. http://dx.doi.org/10.1158/0008-5472.CAN-10-3323
16. FRIDMAN WH, GALON J, DIEU-NOSJEAN MC, CREMER I, FISSON S et al. Immune infiltration in human cancer: prognostic significance and disease control. Curr Top Microbiol Immunol 2011; 344: 1-24.
17. HANAHAN D, WEINBERG RA Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
18. HISCOX S, BARRETT-LEE P, NICHOLSON RI Therapeutic targeting of tumor-stroma interactions. Expert Opin Ther Targets 2011; 15: 609-621.
19. UNGEFROREN H, SEBENS S, SEIDL D, LEHNERT H, HASS R Interaction of tumor cells with the microenvironment. Cell Commun Signal 2011; 9: 18. http://dx.doi.org/10.1186/1478-811X-9-18
20. NICKOLOFF BJ, BEN-NERIAH Y, PIKARSKY E Inflammation and cancer: is the link as simple as we think? J Invest Dermatol 2005; 124: x-xiv. http://dx.doi.org/10.1111/j.0022-202X.2005.23724.x
21. SACCANI A, SCHIOPPA T, PORTA C, BISWAS S, NEBULONI M et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res 2006; 6: 11432-11440. http://dx.doi.org/10.1158/0008-5472.CAN-06-1867
22. MANTOVANI A, ALLAVENA P, SICA A, BALKWILL F Cancer-related inflammation. Nature 2008; 454: 436-444. http://dx.doi.org/10.1038/nature07205
23. BAERISWYL V, CHRISTOFORI G The angiogenic switch in carcinogenesis. Semin Cancer Biol 2009; 19: 329-337. http://dx.doi.org/10.1016/j.semcancer.2009.05.003
24. CHOUAIB S, KIEDA C, BENLALAM H, NOMAN MZ, MAMI-CHOUAIB F, RUEGG C Endothelial cells as key determinants of the tumor microenvironment: interaction with tumor cells, extracellular matrix and immune killer cells. Crit Rev Immunol 2010; 30: 529-545. http://dx.doi.org/10.1615/CritRevImmunol.v30.i6.30
25. BAGLEY RG, WEBER W, ROULEAU C, YAO M, HONMA N et al. Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol 2009; 34: 619-627.
26. KILROY GE, FOSTER SJ, WU X, RUIZ J, SHERWOOD S et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212: 702-709. http://dx.doi.org/10.1002/jcp.21068
27. KUCEROVA L, KOVACOVICOVA M, POLAK S, BOHAC M, FEDELES J, et al. Interaction of human adipose tissuederived mesenchymal stromal cells with breast cancer cells. Neoplasma 2011; 58: 361-370. http://dx.doi.org/10.4149/neo_2011_05_361
28. BERGFELD SA, DECLERCK YA Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 2010; 29: 249-261. http://dx.doi.org/10.1007/s10555-010-9222-7
29. KIDD S, SPAETH E, DEMBINSKI JL, DIETRICH M, WATSON K, et al. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009; 27: 2614-2623. http://dx.doi.org/10.1002/stem.187
30. SALEM HK, THIEMERMANN C Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28: 585-596.
31. SCHAFFLER A, BUCHLER C Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818-27. http://dx.doi.org/10.1634/stemcells.2006-0589
32. HUNG SC, DENG WP, YANG WK, LIU RS, LEE CC, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005; 11: 7749-7756. http://dx.doi.org/10.1158/1078-0432.CCR-05-0876
33. KIDD S, SPAETH E, WATSON K, BURKS J, LU H, et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 2012; 7: e30563. http://dx.doi.org/10.1371/journal.pone.0030563
34. DOMINICI M, LE BLANC K, MUELLER I, SLAPERCORTENBACH I, MARINI F, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317. http://dx.doi.org/10.1080/14653240600855905
35. LE BLANC K, RINGDEN O Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509-525. http://dx.doi.org/10.1111/j.1365-2796.2007.01844.x
36. DJOUAD F, PLENCE P, BONY C, TROPEL P, APPARAILLY F et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837-3844. http://dx.doi.org/10.1182/blood-2003-04-1193
37. HALL B, ANDREEFF M, MARINI F The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007; 263-283.
38. KLOPP AH, GUPTA A, SPAETH E, ANDREEFF M, MARINI F Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 2011; 29: 11-19. http://dx.doi.org/10.1002/stem.559
39. GRISENDI G, BUSSOLARI R, VERONESI E, PICCINNO S, BURNS JS et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. Am J Cancer Res 2011; 1: 787-805.
40. KARNOUB AE, DASH AB, VO AP, SULLIVAN A, BROOKS MW et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563. http://dx.doi.org/10.1038/nature06188
41. AZENSHTEIN E, LUBOSHITS G, SHINA S, NEUMARK E, SHAHBAZIAN D et al. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res 2002; 62: 1093-1102.
42. LAZENNEC G, JORGENSEN C Concise review: adult multipotent stromal cells and cancer: risk or benefit? Stem Cells 2008; 26: 1387-1394. http://dx.doi.org/10.1634/stemcells.2007-1006
43. KIDD S, SPAETH E, KLOPP A, ANDREEFF M, HALL B, MARINI FC The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 2008; 10: 657-667. http://dx.doi.org/10.1080/14653240802486517
44. ZHU W, XU W, JIANG R, QIAN H, CHEN M, et al. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006; 80: 267-274. http://dx.doi.org/10.1016/j.yexmp.2005.07.004
45. PRANTL L, MUEHLBERG F, NAVONE NM, SONG YH, VYKOUKAL J et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate 2010; 7: 1709-1715. http://dx.doi.org/10.1002/pros.21206
46. SHINAGAWA K, KITADAI Y, TANAKA M, SUMIDA T, KODAMA M, et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer 2010; 127: 2323-2333. http://dx.doi.org/10.1002/ijc.25440
47. MUEHLBERG FL, SONG YH, KROHN A, PINILLA SP, DROLL LH et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009; 30: 589-597. http://dx.doi.org/10.1093/carcin/bgp036
48. KUCEROVA L, MATUSKOVA M, HLUBINOVA K, ALTANEROVA V, ALTANER C Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010; 9: 129. http://dx.doi.org/10.1186/1476-4598-9-129
49. CIHOVA M, ALTANEROVA V, ALTANER C Stem cell based cancer gene therapy. Mol Pharm 2011; 8: 1480-1487. http://dx.doi.org/10.1021/mp200151a
50. KUCEROVA L, ALTANEROVA V, MATUSKOVA M, TYCIAKOVA S, ALTANER C Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304-6313. http://dx.doi.org/10.1158/0008-5472.CAN-06-4024
51. CAVARRETTA IT, ALTANEROVA V, MATUSKOVA M, KUCEROVA L, CULIG Z et al. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther 2010; 18: 223-231. http://dx.doi.org/10.1038/mt.2009.237
52. YU JM, JUN ES, BAE YC, JUNG JS Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 2008; 17: 463-473. http://dx.doi.org/10.1089/scd.2007.0181
53. YAN XL, FU CJ, CHEN L, QIN JH, ZENG Q et al. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 2012; 132: 153-164. http://dx.doi.org/10.1007/s10549-011-1577-0
54. GRECO SJ, PATEL SA, BRYAN M, PLINER LF, BANERJEE D et al. AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. Am J Cancer Res 2011; 1: 701-715.
55. KHAKOO AY, PATI S, ANDERSON SA, REID W, ELSHAL MF et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006; 20: 1235-1247.
56. QIAO L, XU ZL, ZHAO TJ, YE LH ZHANG XD Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008; 269: 67-77. http://dx.doi.org/10.1016/j.canlet.2008.04.032
57. ZHU Y, SUN Z, HAN Q, LIAO L, WANG J et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009; 23: 925-933. http://dx.doi.org/10.1038/leu.2008.384
58. COUSIN B, RAVET E, POGLIO S, DE TONI F, BERTUZZI M et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One 2009; 4: e6278. http://dx.doi.org/10.1371/journal.pone.0006278
59. KUCEROVA L, MATUSKOVA M, HLUBINOVA K. BOHOVIC R, FEKETEOVA L et al. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine. Cancer Lett 2011; 311: 101-112. http://dx.doi.org/10.1016/j.canlet.2011.07.014
60. ZHANG W, HUANG C Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity. Cancer Biol Ther 2011; 11: 150-156. http://dx.doi.org/10.4161/cbt.11.2.14623
61. THIERY J, ACLOQUE H, HUANG RY, NIETO MA Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890. http://dx.doi.org/10.1016/j.cell.2009.11.007
62. KLOPP AH, LACERDA L, GUPTA A, DEBEB BG, SOLLEY T et al. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 2010; 5: e12180. http://dx.doi.org/10.1371/journal.pone.0012180
63. MARTIN FT, DWYER RM, KELLY J, KHAN S, MURPHY JM et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010; 124: 317-26. http://dx.doi.org/10.1007/s10549-010-0734-1
64. MORENO-BUENO G, PORTILLOF, CANO A Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-6969. http://dx.doi.org/10.1038/onc.2008.346
65. TOMASKOVIC-CROOK E, THOMPSON EW, THIERY J Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 2009; 11: 213. http://dx.doi.org/10.1186/bcr2416
66. WENDT MK, SMITH JA, SCHIEMANN W Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010; 29: 6485-6498. http://dx.doi.org/10.1038/onc.2010.377
67. SAXENA M, STEPHENS MA, PATHAK H, RANGARAJAN A. Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis 2011; 2: e179. http://dx.doi.org/10.1038/cddis.2011.61
68. CHENG GZ, CHAN J, WANG Q, ZHANG W, SUN CD et al. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 2007; 67: 1979-1987. http://dx.doi.org/10.1158/0008-5472.CAN-06-1479
69. OLMEDA D, MORENO-BUENO G, FLORES JM, FABRA A, PORTILLO F, CANO A. SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells. Cancer Res 2007; 67: 11721-11731. http://dx.doi.org/10.1158/0008-5472.CAN-07-2318
70. CASAS E, KIM J, BENDESKY A, OHNO-MACHADO L, WOLFE CJ ET AL. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 2011; 71: 245-254. http://dx.doi.org/10.1158/0008-5472.CAN-10-2330
71. KIM Y, STOLARSKA MA, OTHMER HG The role of the microenvironment in tumor growth and invasion. Prog Biophys Mol Biol 2011; 106: 353-3579. http://dx.doi.org/10.1016/j.pbiomolbio.2011.06.006
72. FAN F, SCHIMMING A, JAEGER D, PODAR K Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012; 2012: 281261.
73. ANTON K, GLOD J. Targeting the tumor stroma in cancer therapy. Curr Pharm Biotechnol 2009; 10: 185-191. http://dx.doi.org/10.2174/138920109787315088
74. BRABEK J, MIERKE CT, ROSEL D, VESELY P, FABRY B The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal 2010; 8: 22. http://dx.doi.org/10.1186/1478-811X-8-22
75. LUO M, GUAN JL Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 2010; 289: 127-139. http://dx.doi.org/10.1016/j.canlet.2009.07.005
76. FRIEDL P, GILMOUR D Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457. http://dx.doi.org/10.1038/nrm2720
77. RHODES LV, ANTOON JW, MUIR SE, ELLIOTT S, BECKMAN BS et al. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Mol Cancer 2010; 9: 295. http://dx.doi.org/10.1186/1476-4598-9-295
78. LAZENNEC G, RICHMOND A Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010; 16: 133-144. http://dx.doi.org/10.1016/j.molmed.2010.01.003
79. BURGER JA, KIPPS TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006; 107: 1761-1767. http://dx.doi.org/10.1182/blood-2005-08-3182
80. TEICHER BA, FRICKER S CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010; 16: 2927-29. http://dx.doi.org/10.1158/1078-0432.CCR-09-2329
81. LIU S, GINESTIER C, OU SJ, CLOUTHIER SG, PATEL SH et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011; 71: 614-624. http://dx.doi.org/10.1158/0008-5472.CAN-10-0538
82. HICKLIN DJ, ELLIS LM Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027. http://dx.doi.org/10.1200/JCO.2005.06.081
83. LEE TH, SENG S, SEKINE M, HINTON C, FU Y et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med 2007; 4: e186. http://dx.doi.org/10.1371/journal.pmed.0040186
84. TYAN SW, KUO WH, HUANG CK, PAN CC, SHEW JY et al. Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PLoS One 2011; 6: e15313. http://dx.doi.org/10.1371/journal.pone.0015313
85. LO HW, HSU SC, HUNG MC EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2006; 95: 211-218. http://dx.doi.org/10.1007/s10549-005-9011-0
86. ROUSSIDIS AE, THEOCHARIS AD, TZANAKAKIS GN, KARAMANOS NK The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer. Curr Med Chem 2007; 14: 735743. http://dx.doi.org/10.2174/092986707780090963
87. ULIVI P, ZOLI W, MEDRI L, AMADORI D, SARAGONI L et al. c-kit and SCF expression in normal and tumor breast tissue. Breast Cancer Res Treat 2004; 83: 33-42. http://dx.doi.org/10.1023/B:BREA.0000010694.35023.9e
88. DEWAN MZ, AHMED S, IWASAKI Y, OHBA K, TOI M et al. Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 2006; 60: 273-276. http://dx.doi.org/10.1016/j.biopha.2006.06.004